HappycapyGuide

By Connie · Last reviewed: April 2026 — pricing & tools verified · AI-assisted, human-edited · This article contains affiliate links. We may earn a commission at no extra cost to you if you sign up through our links.

How to Use AI for an ENT Practice in 2026: Ambient SOAP, Audiology Triage, Sleep Apnea, Head & Neck Oncology & Owner Scorecard

May 16, 2026 · 16 min read · Healthcare / Otolaryngology

TL;DR for the otolaryngologist-owner

AI earns its keep in an ENT practice when it shortens chart-closure time, pre-reads audiograms + endoscopy video to the right sub-specialty, builds a defensible sinus/tube/tonsil/Inspire/head-and-neck plan, and drives PROMs collection that feeds MIPS and commercial quality scores — without ever making the surgical decision or signing off the final audiogram. The 10 prompts below cover new-patient synthesis, ambient-scribed SOAP, audiogram + endoscopy triage, sinus-CT grading, Inspire/OSA candidacy, head-and-neck oncology tumor-board prep, HIPAA-safe recall, bundled + commercial analysis, denial appeals, and the owner monthly scorecard. Every output requires physician review, a BAA on every vendor, patient AI-use consent per state law, and audiologist + pathologist + radiologist final read on their respective domains.

Who this playbook is for

You own or co-manage a 1-6 physician ENT / otolaryngology practice. Your mix is some combination of general otolaryngology, rhinology (sinus, allergy, rhinoplasty), otology/neurotology (tube, ossiculoplasty, stapes, cochlear implant workup), audiology + hearing aid dispensing, allergy testing + immunotherapy (SCIT/SLIT), sleep medicine + Inspire implant, head-and-neck oncology, pediatric ENT, or facial plastics. You take commercial, Medicare, Medicare Advantage, Medicaid, and some workers' comp / auto. You likely report MIPS under the 2026 Otolaryngology MVP or Merit-based Incentive Payment System. You may run in-office allergy, sleep study, audiology, and balloon sinuplasty. Your pain points are chart-closure catch-up, PA denials on sinus CT + MRI + septoplasty + Inspire + hearing aid benefits, hearing-aid dispensing margin, and pediatric tube + tonsil volume during cold/flu season.

Why ENT is different from general medical practice

The otolaryngologist-owner AI stack (2026)

10 copy-paste AI prompts for the otolaryngologist-owner

1) New-patient intake synthesis + red-flag triage

You are the ENT MA/scribe synthesizing a new-patient intake for a <sub-specialty: rhinology/otology/pedi ENT/sleep/head-and-neck/facial plastics> physician. Read this packet (chief complaint, HPI, PMH, PSH, FH, SH, meds, allergies, prior imaging, prior operative notes, prior audiograms, sleep study, allergy panel): <paste intake> Output in this order: (1) One-line chief complaint + laterality + duration (2) Mechanism / onset: acute vs chronic, viral trigger, trauma, NSAID/ASA, voice overuse, noise exposure, smoke/vape, environmental allergen (3) Symptom severity scales: SNOT-22 (sinus), TNSS (allergy), NOSE (nasal obstruction), Epworth + STOP-BANG (sleep apnea), HHIE-S (hearing), VHI (voice), RSI (reflux), UW-QOL (head-and-neck cancer) (4) Prior treatment sequence: OTC/Rx intranasal steroid → antihistamine → saline rinse → antibiotic course → allergy panel → CPAP trial → hearing aid trial → prior surgery (5) Imaging available (type/date/facility) with one-line prior-radiologist impression (if sinus CT, note Lund-Mackay score) (6) Red flags requiring same-day escalation: unilateral epistaxis + mass, unilateral hearing loss + tinnitus (r/o VS/IAC), progressive dysphagia/odynophagia > 3 weeks (r/o H&N cancer), hoarseness > 2 weeks + smoker, neck mass > 2 weeks adult, facial nerve weakness, acute sensorineural hearing loss (ISSNHL window), orbital/intracranial sinusitis complication, airway compromise (7) Pre-op optimization flags: BMI > 40 (Inspire candidacy), uncontrolled OSA, anticoagulant management, pediatric ASA III+ tonsillectomy planning (8) PA/prior-auth likelihood for next step (sinus CT, MRI IAC, septoplasty, FESS, Inspire, hearing aid, allergy testing) by payer Output a 5-line SOAP skeleton the physician will edit. Do not diagnose. Do not recommend surgery. Flag any red flag in ALL CAPS at the top. The physician and MA will verify every line before it enters the chart.

2) Ambient-scribed ENT SOAP with CPT suggestions

You are the ambient scribe for an ENT visit. Input is the de-identified transcript from DeepScribe/Abridge/Suki/DAX Copilot/Heidi with a signed BAA. Patient consented to AI-assisted documentation per state law. <paste transcript> Produce a SOAP note: - Subjective: CC, HPI with OLDCARTS, pertinent positives/negatives, validated symptom scale (SNOT-22/TNSS/NOSE/Epworth/HHIE-S/VHI/RSI), prior treatment - Objective: vitals, focused ENT exam (ear: auricle/EAC/TM with pneumatic otoscopy; nose: septum/turbinates/polyps by nasal endoscopy score Lund-Kennedy; oral/OP: dentition/tongue/tonsils Brodsky 1-4/pharynx; neck: thyroid/LN/parotid/SMG; cranial nerves II-XII; voice quality), flexible laryngoscopy findings if performed - Diagnostics: audiogram/tymp (audiologist interprets), sinus CT Lund-Mackay 0-24 (radiologist reads), allergy panel (SLIT/SCIT panel), sleep study AHI/RDI/ODI - Assessment: ICD-10 with laterality (J32.0-J32.9 sinusitis, H65-H66 OM, H90.A hearing loss, J34.2 septal deviation, J33 polyp, G47.33 OSA, C76.0 neck cancer unspecified) - Plan: medical management (saline rinse + INS + short oral steroid with caution + antibiotic only if bacterial), allergy pathway (SCIT vs SLIT), CPAP trial vs Inspire workup, in-office procedure vs OR, return interval Suggest CPT: 99203-99205 new or 99213-99215 est, 31231 (diagnostic nasal endoscopy), 31237 (endoscopic debridement), 31295-31298 (balloon sinuplasty), 92551/92552/92557 (hearing test), 92588 DPOAE, 92567 (tympanometry), 95004/95024 (allergy testing), 95165 (immunotherapy prep), 69436 (tube RT/LT), 42820 (T&A), 64568 (Inspire), 60240 (thyroid lobectomy). Flag any -25 modifier rationale. The physician must verify every element before signing.

3) Audiogram + tympanogram triage + audiologist queue

You are the audiology triage nurse using AI pattern-recognition (Otonomy / Jacoti / Sycle / Blueprint Solutions OMS / AuDNet). AI output is clinical decision support, not final interpretation. Audiologist interprets every audiogram. For today's queue of audiograms and tympanograms, produce for each patient: (1) Patient initials, MRN, test type, age, clinical indication (2) Audiogram pattern flag: normal / mild SNHL / moderate SNHL / severe SNHL / profound SNHL / mild-to-moderate CHL / mixed; asymmetry alert (10 dB difference at 2+ frequencies OR 15 dB at single frequency — triggers MRI IAC workup to r/o vestibular schwannoma), noise-induced notch at 4 kHz, presbycusis pattern, Carhart notch (3) Tympanometry type (A/Ad/As/B/C) + static admittance + pressure (4) Speech: SRT, WRS with PB word list; roll-over for retrocochlear concern (5) Hearing-aid candidacy flag: PTA > 25 dB with aidable frequencies, HHIE-S score, prior hearing aid failure (6) Cochlear implant candidacy flag: bilateral severe-to-profound SNHL with AzBio < 60% in the better ear aided — triggers CI eval referral (7) Urgency tier: STAT (ISSNHL within 2-week steroid window, asymmetric SNHL + facial nerve symptom), same-week (new asymmetric SNHL for MRI IAC), routine (age-related hearing loss hearing-aid workup) (8) Incidental findings auto-escalate Do not make the diagnosis. Audiologist final read stays with a licensed audiologist per state scope. Document AI output as adjunct in the chart with model name and version. Flag any STAT item at the top of the queue in ALL CAPS.

4) Sinus CT grading + FESS / balloon candidacy

You are the sinus pre-op planning assistant for a <FESS / balloon sinuplasty / septoplasty + turbinate reduction / revision FESS>. Inputs: sinus CT images (radiologist report + image access), SNOT-22, prior medical management (intranasal steroid > 8 weeks, saline rinse, short oral steroid course, targeted antibiotic), allergy testing, nasal endoscopy findings with Lund-Kennedy score. <paste case packet> Produce: (1) Lund-Mackay CT score (0-24): maxillary, anterior ethmoid, posterior ethmoid, frontal, sphenoid, osteomeatal complex — each 0/1/2 per side (2) Variant anatomy checklist: concha bullosa, Haller cell, Onodi cell, supreme turbinate, dehiscent lamina papyracea, thin skull base in Keros I/II/III, internal carotid artery dehiscence, optic nerve dehiscence, accessory maxillary ostium, septal deviation/spur (3) CMS + commercial medical-necessity narrative: failed medical management (INS > 8 weeks + saline + targeted antibiotic + allergy management if indicated), persistent symptoms SNOT-22 > 20, CT findings consistent with symptoms, payer-specific policy bullets (4) FESS vs balloon vs hybrid decision framework: balloon for maxillary/frontal/sphenoid ostia without tissue removal; FESS for ethmoid disease, polyps, fungal, revision, concha bullosa resection (5) Implant decision: Intersect PROPEL / SINUVA steroid-eluting stent — review payer policy for separate C9257 coding (6) Anesthesia + antibiotic prophylaxis plan (7) Pediatric considerations: adenoidectomy before FESS in pediatric CRS, watchful waiting for mild disease (8) Pre-op consent talking points including AI-use disclosure if state-required (9) Post-op debridement schedule POD 7, 14, 21 with billing 31237 (10) PROMs plan: SNOT-22 pre-op + 3mo + 6mo + 12mo Do not finalize the plan. The operating surgeon confirms the indication on personal exam + imaging review and signs the plan.

5) OSA + Inspire + CPAP candidacy workup

You are the sleep + Inspire coordinator. Inputs: sleep study (in-lab PSG or HSAT WatchPAT/NightOwl/Lofta), BMI, neck circumference, Epworth, STOP-BANG, CPAP adherence data (ResMed myAir, Philips DreamMapper post-recall, Fisher&Paykel Infosmart), DISE results if performed, comorbidities. <paste case packet> Produce: (1) Sleep study interpretation summary (sleep-medicine physician reads — AI summarizes): AHI, RDI, ODI, nadir SpO2, time < 90%, REM AHI, supine AHI, positional component, central vs obstructive, periodic limb movement index (2) OSA severity stratification: mild 5-15, moderate 15-30, severe > 30; REM-predominant; positional (3) CPAP trial status: adherence < 4 hrs/night on 70% of nights over 30 days = failed; mask interface issue; pressure tolerance; APAP range (4) Inspire (hypoglossal nerve stimulation) candidacy per Inspire Medical + FDA expanded 2023 indication: AHI 15-65 (standard) or 15-100 (expanded), BMI < 32 (standard) or < 35 or < 40 by state/payer variation, age 18+ (or Down syndrome age 13+), failed or intolerant CPAP, DISE without complete concentric collapse at palate, no severe cardiopulmonary disease. 2025 expanded criteria allowed some higher BMI with DISE confirmation — cite current Inspire + Medicare LCD + commercial policy (5) Alternative procedures: MMA (maxillomandibular advancement), UPPP + tonsillectomy, expansion sphincter pharyngoplasty, lateral pharyngoplasty, base-of-tongue reduction (coblation, RFA, TORS lingual tonsillectomy), septoplasty + turbinate reduction, nasal valve repair (6) DISE plan: schedule DISE with propofol TCI, VOTE scoring, Pringle maneuver, jaw thrust test (7) Pre-op optimization: weight loss program, positional therapy trial, myofunctional therapy, mandibular advancement device trial (8) PA narrative for Inspire: Aetna / UHC / BCBS / Medicare LCD with verbatim payer-policy bullet matching (9) Post-implant follow-up: 1-month activation, titration, efficacy DME-home-sleep-test at 3-6 months, annual follow-up (10) PROMs: ESS pre vs post, ODI, FOSQ Do not finalize. The sleep-medicine physician and ENT surgeon own the decision. Inspire reps cannot direct clinical decisions and cannot be in the OR without credentialed-vendor-rep compliance.

6) Head-and-neck oncology tumor-board prep

You are the head-and-neck oncology coordinator preparing cases for Friday's multidisciplinary tumor board (ENT/head-and-neck surgery, medical oncology, radiation oncology, radiology, pathology, speech-language pathology, nutrition, dental oncology, social work). <paste new cases + recurrent cases> For each case, produce a one-page tumor-board brief: (1) Patient initials, MRN, age, sex, smoking + alcohol history, HPV status if oropharynx (2) Presenting symptom + duration, prior imaging + biopsy path (3) Site + subsite: oral cavity (lip/tongue/FOM/RMT/buccal/hard palate/gingiva), oropharynx (tonsil/base of tongue/soft palate/pharyngeal wall), hypopharynx (pyriform/postcricoid), larynx (glottic/supraglottic/subglottic), nasopharynx, salivary (parotid/SMG), thyroid, skin with H&N drainage, unknown primary (4) TNM 8th edition staging: T, N, M, AJCC stage, p16/HPV modifier for oropharynx (5) Imaging summary (radiologist reads — AI summarizes only): CT neck with contrast, MRI neck, PET/CT, US-guided FNA path (6) Pathology (pathologist reads — AI summarizes only): histology, grade, HPV p16, PD-L1 CPS, molecular (NGS Tempus xT / Foundation / Caris if indicated) (7) Treatment options per NCCN 2026 Head and Neck Cancer Guideline: surgery (TORS vs open, neck dissection levels, margins), definitive RT vs chemo-RT (cisplatin vs cetuximab vs immunotherapy pembrolizumab/nivolumab per KEYNOTE-048), induction chemo, de-escalation protocols for HPV+ OPSCC (per NRG-HN002/HN005, ECOG-ACRIN E3311 results) (8) Reconstruction plan if surgery: primary closure vs local flap vs radial forearm vs ALT vs fibula free flap; tracheostomy + PEG plan; speech and swallow pre-hab (9) Clinical trial eligibility (ClinicalTrials.gov search for site + stage) (10) Functional outcomes counseling: speech, swallow (MBSS/FEES), taste, xerostomia, mandibular ORN risk, shoulder dysfunction after neck dissection, feeding tube duration Tumor board votes. Do not finalize AI output. Oncologist, radiation oncologist, and pathologist own the recommendation. Physician documents the tumor-board decision in the chart with date and attendees.

7) HIPAA-safe recall across allergy / audiology / post-op / annual

You are the recall coordinator. Segment the practice panel into recall cohorts using only protected-health-information-minimum fields with a signed BAA on the messaging platform (Weave/Doctible/Phreesia/Klara/NexHealth/Solutionreach): Cohort A — Allergy immunotherapy build-up overdue: patients on SCIT/SLIT with missed build-up visits > 2 weeks Cohort B — Post-FESS debridement due: POD 7, 14, 21 CPT 31237 follow-up Cohort C — Hearing aid 30-day / 90-day / annual clean-and-check: post-fit verification, REM remeasurement, battery/rechargeable service Cohort D — CPAP adherence outreach: patients with < 4 hrs/night on 70% of nights over 30 days — mask refit, pressure adjustment, or Inspire workup referral Cohort E — Annual ENT follow-up: post-FESS 1-yr, post-Inspire annual, post-tonsil/adeno 1-yr, chronic OM tube check at 6mo + 1yr, head-and-neck cancer surveillance per NCCN (q1-3 mo year 1, q2-4 mo year 2, q4-6 mo years 3-5, annually after 5) Cohort F — Pediatric ENT seasonal: fall cold/flu tube surveillance, spring allergy workup For each cohort, draft a 2-sentence SMS + a 40-word email, include one-click reschedule link, opt-out language, and call a human line for questions. SMS at or above 8am and at or below 9pm patient local, two-party-consent states honored (CA/FL/MA/WA/PA/IL/MT/NH/CT/MD). No PHI in SMS preview. Log recall attempts in the EHR. TCPA + state mini-TCPA + HIPAA Privacy Rule + FTC Act §5 compliance required.

8) Hearing-aid dispensing margin + OTC rule analysis

You are the audiology + hearing-aid dispensing analyst. Inputs: 12-month dispensing data (manufacturer, style ITE/BTE/RIC/CIC, technology tier, cost of goods, list price, return rate within 30-day trial, repair rate at 1yr/2yr/3yr, customer satisfaction survey), OTC hearing aid competitive landscape post-FDA 2022 final rule, insurance benefit carriers (UHC Hearing, Amplifon, TruHearing, HearUSA, Epic Hearing). <paste dispensing dataset, de-identified> Produce: (1) Margin-per-device: list − COGS, by manufacturer, by style, by technology tier, by audiologist (2) Manufacturer mix: Oticon / Phonak / ReSound / Signia / Starkey / Widex / Unitron / Rexton — volume + margin + return rate (3) Return rate driver: first-fit algorithm failure (Oticon More / Phonak Target / ReSound Smart 3D / Signia Connexx), speech-in-noise complaint, occlusion, cosmetic, price shock, OTC substitution (4) Insurance benefit pattern: UHC Hearing / Amplifon / TruHearing / HearUSA / Epic Hearing reimbursement, MA plan sub-cap, state Medicaid pediatric benefit, VA CCN rates (5) OTC competitive pressure: Jabra Enhance / Sony CRE / Lexie by Bose / Eargo / Audicus / Hearing Lab Technology — mild-moderate SNHL cannibalization; build-your-bundled-care moat with REM + counseling + trial + remote care (6) Audiologist productivity: clinical-hour utilization, fittings/week, returns/week, revenue-per-hour (7) Tele-audiology remote-care adoption: remote programming, Phonak Remote Support, Oticon RemoteCare, ReSound Assist, Signia TeleCare (8) OTC vs Rx decision tree for mild-moderate SNHL: when to recommend OTC (low complexity, self-motivated, cost-sensitive) vs full audiology care (asymmetric, tinnitus, CAPD suspicion, cognitive) (9) 3 high-impact interventions for next quarter with projected margin lift (10) State hearing-aid dispenser law + AAA ethics + ASHA scope compliance check Owner owns every decision. Do not change manufacturer purchasing based on AI output alone — vendor contracts, AKS/Stark review, and audiologist preference all apply.

9) Denial appeal + septoplasty / FESS / Inspire / MRI PA letter

You are the appeals coordinator. Inputs: denial letter (payer, denial code, date, reviewer), clinical packet (notes, imaging reports, audiogram, sleep study, failed medical management with dates, SNOT-22/NOSE/Epworth scores), payer medical policy (e.g., Aetna CPB 0004 septoplasty, UHC MRI IAC, BCBS balloon sinuplasty, Cigna 0243 Inspire, Medicare LCD L33382 hypoglossal nerve stim, CMS NCD 50.3 cochlear implant). <paste denial + clinical packet> Produce a level 1 appeal letter: (1) Case caption: member, DOB, claim/auth #, denial code, service requested, date of service (2) Clinical summary: diagnosis with ICD-10, failed medical management sequence with dates (INS > 8 weeks, saline rinse, targeted antibiotic culture-directed when possible, allergy management, CPAP trial with adherence data, DISE results), imaging/audiogram/sleep-study findings correlating to symptoms, validated symptom scale score, exam findings (3) Medical-necessity argument tracking the payer's own policy language — cite the exact policy section number and bullet (4) Evidence citations: AAO-HNS clinical practice guidelines, NCCN Head and Neck Cancer, American Academy of Audiology, Medicare LCDs, NCDs, peer-reviewed literature (less than or equal to 5 years when possible, cite specifically — no hallucinated citations, every citation verified by a human before submission) (5) Request: overturn denial + approve <service> + peer-to-peer if level 1 is upheld (6) Supporting documents checklist attached (7) Signature block for the physician; letter is drafted by AI and signed/verified by the physician If level 1 is denied, escalate to level 2 external review per state insurance department + ERISA § 503 if self-funded. Log every appeal in the PA-denial tracker with outcome. Never submit AI-drafted legal or clinical content unreviewed — a bad citation or a misstated fact creates malpractice and bad-faith exposure.

10) HIPAA-safe review reply + state-compliant ad + owner monthly scorecard

You are the owner's reputation + marketing + operations assistant. (A) Review reply: for every new 1-3 star or 5-star Google/Healthgrades/Vitals/Yelp/Zocdoc review, draft a reply that (i) thanks the reviewer without acknowledging treatment or identity, (ii) offers offline contact via office manager direct line + email, (iii) references the specific service category only if it is already in the public review, (iv) NEVER confirms or denies the reviewer was ever a patient, (v) complies with HIPAA 45 CFR 164.502, FTC Endorsement Guides 2023 + 2024-2025, FTC Fake Reviews Rule 16 CFR 465 ($51,744/violation FY 2026), AMA CEJA, state truth-in-advertising (CA B&P §17500 / FL §817.06 / NY GBL §349 / TX DTPA §17.46), and state medical-board advertising rules. No incentive-for-review. No fake or AI-generated reviews. (B) Ad draft: for a specific service line (sinus, sleep apnea + Inspire, hearing aids, allergy, pediatric ENT, voice, head-and-neck), produce an ad that names the service, references any measurable truthful claim (e.g., published outcome data, board certification, Inspire-certified implanting surgeon status, academy fellowship) with source, avoids superlatives ("best", "#1", "painless") unless substantiated with independent data, includes state-required disclaimers (CA B&P 651 specialty claims, TX TMB rules, FL free-consult ad standards), flags payer network, and complies with AMA ethics + state medical-board advertising rules. FDA off-label claims for devices are prohibited. (C) Monthly owner scorecard: visit volume by CPT and sub-specialty, per-physician wRVU, new-patient vs established ratio, PA denial + appeal-win rate, hearing-aid dispensing margin + return rate, Inspire activation + annual-follow-up rate, FESS + balloon + tonsil + tube volume, head-and-neck oncology case volume, SNOT-22/NOSE/Epworth/HHIE-S PROMs delta pre-op to 90d, days-in-AR (90+), patient satisfaction (Press Ganey / NPS), MIPS composite score, chart-closure compliance (less than 48hr), physician burnout pulse, staff turnover, and the one hard decision for this month. State-compliant ad reminder: renew state license by <date>, DEA renewal, malpractice renewal, CMS revalidation, hearing-aid dispenser license renewal.

Compliance floor

Common mistakes

60-day rollout

Ready to run this in your practice?

Copy the 10 prompts above into your EHR + ambient stack. Start with the new-patient intake synthesis and ambient SOAP — those alone should cut chart-closure time by 30-45 minutes per clinic day. Layer audiogram + sinus CT triage, Inspire candidacy, and hearing-aid dispensing analysis next. The physician signs every note, owns every surgical and clinical decision, and reviews every AI output. Audiologist owns audiogram interpretation. Radiologist owns imaging. Pathologist owns tissue. AI is the scribe, triage nurse, and analyst — never the physician.

← Back to all blog posts

SharePost on XLinkedIn
—Was this helpful?

Get the best AI tools tips — weekly

Honest reviews, tutorials, and Happycapy tips. No spam.

You might also like

How-To Guide

How to Use AI for a Tax Law Firm in 2026: IRS Controversy, OIC, Tax Court, FBAR, Estate Planning & Managing-Partner Scorecard

17 min

How-To Guide

How to Use AI for a Home Builder in 2026: Takeoff, Scheduling, Change Orders, Warranty & Owner Scorecard

17 min

How-To Guide

How to Use AI for a Concrete Contractor in 2026: Estimating, Mix Design, Pour Schedule, Cold-Joint & Owner Scorecard

15 min

How-To Guide

How to Use AI for an Orthopedic Practice in 2026: Ambient SOAP, Imaging Triage, Surgical Planning & Owner Scorecard

16 min

Comments